LifeMD to Participate in Upcoming Investor Conferences
LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript
LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates
LifeMD Reports First Quarter 2026 Results
LifeMD to Report First Quarter 2026 Financial Results on May 6
LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?
LifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management
LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
LifeMD, Inc. (NASDAQ:LFMD) Given Average Recommendation of “Moderate Buy” by Brokerages
LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team
LifeMD: Wegovy Pill, Net Cash, And Low Multiple Sets Up Longs For Possible Alpha
Uniqure To Rally Around 92%? Here Are 10 Top Analyst Forecasts For Wednesday
LifeMD, Inc. (LFMD) Q4 2025 Earnings Call Transcript
LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates
LifeMD Reports Fourth Quarter and Full Year 2025 Results
LifeMD to Participate in Two Investor Conferences During March
LifeMD: Still My Favorite Bargain On The Market
LifeMD to Report Fourth Quarter 2025 Financial Results on March 9
LifeMD: Pure Telehealth Play With In-House Pharmacy Integration
Analyzing LifeMD (NASDAQ:LFMD) & Avantor (NYSE:AVTR)
Kuehn Law Encourages Investors of LifeMD, Inc. to Contact Law Firm
LifeMD, Inc. (NASDAQ:LFMD) Given Consensus Rating of “Moderate Buy” by Brokerages
Kuehn Law Encourages Investors of LifeMD, Inc. to Contact Law Firm
LifeMD (NASDAQ:LFMD) vs. Concentra Group Holdings Parent (NYSE:CON) Financial Contrast
LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A.
LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill
LifeMD (NASDAQ:LFMD) vs. Eurofins Scient (OTCMKTS:ERFSF) Head to Head Survey
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME's America's Growth Leaders of 2026
Benzinga Bulls And Bears: Nvidia, Webull, Netflix — And Tech Stocks Face Worst Sell-Off Since April
TDOC vs. LFMD: Which Telehealth Stock Is Better for Your Portfolio?
LifeMD, Inc. (LFMD) Q3 2025 Earnings Call Transcript
LifeMD, Inc. (LFMD) Reports Q3 Loss, Misses Revenue Estimates
LifeMD Stock Plummets After Q3 Earnings: Here's Why
LifeMD Reports Third Quarter 2025 Results
LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk
26,361 Shares in LifeMD, Inc. $LFMD Acquired by Campbell & CO Investment Adviser LLC
Wall Street Week Ahead
Acadian Asset Management LLC Acquires Shares of 281,244 LifeMD, Inc. $LFMD
LifeMD to Participate in the BTIG Digital Health Forum
LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17
Y Intercept Hong Kong Ltd Makes New Investment in LifeMD, Inc. $LFMD
LifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
HIMS vs. LFMD: Which Telehealth Stock Is the Better Investment Now?
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LFMD FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Investors of LifeMD Upcoming Lead Plaintiff Deadline on Monday, October 27, 2025
Class Action Filed Against LifeMD, Inc. (LFMD) Seeking Recovery for Investors - Contact The Gross Law Firm
LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – LFMD